New highly radioactive particles derived from Fukushima Daiichi Reactor Unit 1: Properties and environmental impacts.

Fukushima Nuclear Accident Humans Nuclear Power Plants Radiation Monitoring Radioactivity Silicon Dioxide
Boron Cesium Fukushima Daiichi Nuclear Power Plant Isotopic analysis Radioactive particle Unit 1

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
15 Jun 2021
Historique:
received: 23 10 2020
revised: 30 01 2021
accepted: 31 01 2021
entrez: 4 5 2021
pubmed: 5 5 2021
medline: 6 5 2021
Statut: ppublish

Résumé

A contaminated zone elongated toward Futaba Town, north-northwest of the Fukushima Daiichi Nuclear Power Plant (FDNPP), contains highly radioactive particles released from reactor Unit 1. There are uncertainties associated with the physio-chemical properties and environmental impacts of these particles. In this study, 31 radioactive particles were isolated from surface soils collected 3.9 km north-northwest of the FDNPP. Two of these particles have the highest particle-associated

Identifiants

DOI: 10.1016/j.scitotenv.2021.145639 PMID: 33940743
pubmed: 33940743
pii: S0048-9697(21)00707-5
doi: 10.1016/j.scitotenv.2021.145639
pii:
doi:

Substances chimiques

Silicon Dioxide 7631-86-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

145639

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kazuya Morooka (K)

Department of Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Eitaro Kurihara (E)

Department of Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Masato Takehara (M)

Department of Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Ryu Takami (R)

Department of Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Kazuki Fueda (K)

Department of Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Kenji Horie (K)

National Institute of Polar Research, 10-3, Midori-cho, Tachikawa-shi, Tokyo 190-8518, Japan; Department of Polar Science, The Graduate University for Advanced Studies (SOKENDAI), Shonan Village, Hayama, Kanagawa 240-0193, Japan.

Mami Takehara (M)

National Institute of Polar Research, 10-3, Midori-cho, Tachikawa-shi, Tokyo 190-8518, Japan.

Shinya Yamasaki (S)

Faculty of Pure and Applied Sciences and Center for Research in Isotopes and Environmental Dynamics, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.

Toshihiko Ohnuki (T)

Laboratory for Advanced Nuclear Energy, Institute of Innovative Research, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.

Bernd Grambow (B)

SUBATECH, IMT Atlantique, CNRS-IN2P3, the University of Nantes, Nantes 44307, France.

Gareth T W Law (GTW)

Radiochemistry Unit, Department of Chemistry, The University of Helsinki, Helsinki 00014, Finland.

Joyce W L Ang (JWL)

Radiochemistry Unit, Department of Chemistry, The University of Helsinki, Helsinki 00014, Finland.

William R Bower (WR)

Radiochemistry Unit, Department of Chemistry, The University of Helsinki, Helsinki 00014, Finland.

Julia Parker (J)

Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, UK.

Rodney C Ewing (RC)

Department of Geological Sciences and Center for International Security and Cooperation, Stanford University, Stanford, CA 94305-2115, USA.

Satoshi Utsunomiya (S)

Department of Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan. Electronic address: utsunomiya.satoshi.998@m.kyushu-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Environnement et santé publique › Santé publique › Accidents › Émission de source de risque radioactif › Accident nucléaire de Fukushima › New highly radioactive particles derived from...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › New highly radioactive particles derived from...
questionsmedicales.fr › Établissements non médicaux publics ou privés › Installations industrielles et de fabrication › Centrales énergétiques › Centrales nucléaires › New highly radioactive particles derived from...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Hygiène radiologique › Contrôle des radiations › New highly radioactive particles derived from...
questionsmedicales.fr › Phénomènes physiques › Radioactivité › New highly radioactive particles derived from...
questionsmedicales.fr › Produits chimiques inorganiques › Composés du silicium › Silice › New highly radioactive particles derived from...